ArticleHuman vaccines & immunotherapeutics2021
Who should be prioritised for COVID-19 vaccination?
Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04650035 (The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak), which is not on this map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak : A Survey
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.
- Recommendations for improving maternal health services in Indonesian primary care under the COVID-19 pandemic: Results of a systematic review and appraisal of international guidelines.Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives · 2023Pooled it
- Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis.Frontiers in public health · 2022Pooled it
- Predictors of COVID-19 Vaccination Intention and Behavior Among Young People in a European Union Country With Low COVID-19 Vaccination Rates: Cross-Sectional Study.JMIR public health and surveillance · 2025Article
- Association between friends' hesitancy and personal COVID-19 vaccine hesitancy among Chinese medical staff.Human vaccines & immunotherapeutics · 2024Article
- Article
- COVID-19 vaccine and non-syndromic orofacial clefts in five arab countries. A case-control study.Clinical oral investigations · 2024Article
- Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis.Clinical and experimental vaccine research · 2024Review
- The effect of COVID-19 vaccination status on all-cause mortality in patients hospitalised with COVID-19 in Hungary during the delta wave of the pandemic.GeroScience · 2024Article
- Sex differences in the relationship between post-vaccination adverse reactions, decision regret, and WTP for the booster dose of COVID-19 vaccine in Taizhou, China.Preventive medicine reports · 2024Article
- Mortality trends in people with disabilities before and during the COVID-19 pandemic in South Korea, 2017-2022.Frontiers in public health · 2024Article
- Characterization and predictive risk scoring of long COVID in a south indian cohort after breakthrough COVID infection; a prospective single centre study.BMC infectious diseases · 2023Observational
- Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12-17 Years against COVID-19 Infection in Qatar.Vaccines · 2023Article
- College students' influence on COVID-19 vaccination uptake among seniors in China: a protocol of combined cross-sectional and experimental study.BMC public health · 2023Article
- Changes in tourist mobility after COVID-19 outbreaks.Annals of tourism research · 2023Article
- Article
- Post-vaccination adverse reactions, decision regret, and willingness to pay for the booster dose of COVID-19 vaccine among healthcare workers: A mediation analysis.Human vaccines & immunotherapeutics · 2022Article
- COVID-19 vaccine acceptance among cold-chain workers in Shenzhen, China: A cross-sectional survey.Human vaccines & immunotherapeutics · 2022Article
- Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China.Human vaccines & immunotherapeutics · 2022Article
- COVID-19 Vaccination and Mental Stress within Diverse Sociodemographic Groups.International journal of environmental research and public health · 2022Article
- Age discrimination, the right to life, and COVID-19 vaccination in countries with limited resources.The Journal of social issues · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.